Improved effects of formoterol-budesonide combination on residual eosinophilic inflammation in asthmatic peripheral airway

H. Ohbayashi, M. Adachi (Mizunami, Tokyo, Japan)

Source: Annual Congress 2013 –Asthma drugs: new findings
Session: Asthma drugs: new findings
Session type: Thematic Poster Session
Number: 4123
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Ohbayashi, M. Adachi (Mizunami, Tokyo, Japan). Improved effects of formoterol-budesonide combination on residual eosinophilic inflammation in asthmatic peripheral airway. Eur Respir J 2013; 42: Suppl. 57, 4123

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Atomization inhalation on the NO content in the airway of patients with bronchial asthma
Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases
Year: 2016

Dysphonia in asthmatic women using inhaled corticosteroids: It is not only a laryngeal inflammation
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016


Short-term effects of bronchial thermoplasty on pulmonary function in patients with severe asthma
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016

B2-adrenoceptor genotype16 influences airway calibre but not hyperresponsiveness in asthmatics using regular B2-agonist in addition to inhaled corticosteroids
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013


The usefulness of FeNO and the mannitol test in detecting airway eosinophilia in asthma patients with uncontrolled symptoms
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014


Effect of different inhalation methods on the airway clearance in moderate and severe AECOPD
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016


Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016


Efficacy of carbamazepine in treatment of bronchial asthma
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013


Using induced sputum cell counts to guide management of difficult-to-treat asthmatics
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013


The effect of vitamin D therapy on airway reactivity and airway inflammation in asthmatic children
Source: Annual Congress 2013 –Preschool wheeze
Year: 2013

Monitoring of airway resistance (Raw) in exacerbation of asthma
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013


Involvement of airway eosinophilia and airway hyperresponsiveness in management and therapy for COPD>
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Year: 2020

Air trapping in relation to airways inflammation and bronchial responsiveness in patients with respiratory symptoms suggestive of asthma
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014

Changes in symptoms, respiratory function, airway inflammation, and airway hyperresponsiveness over 10 year of inhaled corticosteroid therapy in adult asthma patients
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015


Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016

A novel inhaled PI3Kδ inhibitor, LAS194223 reduces allergen-induced airway inflammation in rat
Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis
Year: 2014

Clinical, functional and inflammatory characteristics in patients with paucigranulocytic asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


Effectively targeting small airways using controlled inhalation for peripheral corticosteroid deposition
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014


Are ultrafine particle inhalers, better for patients with small airway involvement?
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014